Flow Cytometry

Partec developed the key technique in 1968: flow cytometry (FCM).  This is an automated process, which allows cells and particles to be analysed rapidly. The cells to be analysed are marked using DNA or immune markers and fluoresecence dyes. Subsequently, they pass through up to five laser sources in the flow cytometer. When they are stimulated by the laser, aditionally to scatter light the marked cells emit fluorescent light which is detected and amplified by optoelectronic components. The subsequent evaluation is performed on a computer, with the results measured for each cell being registered. Flow Cytometry allows for up to 16 different cell properties to be tested for at the same time - in more than 100,000 cell per minute. 

The flow cytometry devices can be used in a wide range of applications in healthcare and medical diagnostics (e.g. Immunology, leukemia, lymphoma, HIV/AIDS), cell biology, microbiology, biotechnology, agroscience, plant bredding, aquaculture, and for quality control in pharmaceutical industry as well as in food and beverage industries.

Copyright © Sysmex Europe SE. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.